Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY

v3.20.2
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($)
Series C Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Total
Balance at Dec. 31, 2018 $ 41 $ 30,386 $ 101,921,707 $ 134,331 $ (93,150,198) $ 8,936,267
Balance (in shares) at Dec. 31, 2018 4,092 3,038,592        
Stock-Based Compensation     469,096     469,096
Issuance of Shares of Common Stock from Warrant Exercises   $ 67 31,933     32,000
Issuance of Shares of Common Stock from Warrant Exercises (in shares)   6,666        
Cancellation of Restricted Stock   $ (2) 2     0
Cancellation of Restricted Stock (in shares)   (209)        
Foreign Currency Translation Adjustment       857   857
Net Loss         (966,463) (966,463)
Balance at Jun. 30, 2019 $ 41 $ 30,451 102,422,738 135,188 (94,116,661) 8,471,757
Balance (in shares) at Jun. 30, 2019 4,092 3,045,049        
Balance at Mar. 31, 2019 $ 41 $ 30,384 102,154,615 133,833 (92,279,389) 10,039,484
Balance (in shares) at Mar. 31, 2019 4,092 3,038,383        
Stock-Based Compensation     236,190     236,190
Issuance of Shares of Common Stock from Warrant Exercises   $ 67 31,933     32,000
Issuance of Shares of Common Stock from Warrant Exercises (in shares)   6,666        
Foreign Currency Translation Adjustment       1,355   1,355
Net Loss         (1,837,272) (1,837,272)
Balance at Jun. 30, 2019 $ 41 $ 30,451 102,422,738 135,188 (94,116,661) 8,471,757
Balance (in shares) at Jun. 30, 2019 4,092 3,045,049        
Balance at Dec. 31, 2019 $ 41 $ 40,778 106,689,065 139,465 (100,246,894) 6,622,455
Balance (in shares) at Dec. 31, 2019 4,092 4,077,755        
Stock-Based Compensation     342,971     342,971
Stock Issuance Costs           (498,687)
Issuance of Common Stock in Offering, Net of Offering Costs   $ 5,000 4,496,313     4,501,313
Issuance of Common Stock in Offering, Net of Offering Costs (in shares)   500,000        
Issuance of Common Stock from Restricted Stock Award Grants   $ 490 (490)      
Issuance of Common Stock from Restricted Stock Award Grants (in shares)   (49,000)        
Cancellation of Restricted Stock           490
Foreign Currency Translation Adjustment       166   166
Net Loss         (3,669,301) (3,669,301)
Balance at Jun. 30, 2020 $ 41 $ 46,268 111,527,859 139,631 (103,916,195) 7,797,604
Balance (in shares) at Jun. 30, 2020 4,092 4,626,755        
Balance at Mar. 31, 2020 $ 41 $ 46,268 111,330,808 139,653 (102,199,094) 9,317,676
Balance (in shares) at Mar. 31, 2020 4,092 4,626,755        
Stock-Based Compensation     197,051     197,051
Foreign Currency Translation Adjustment       (22)   (22)
Net Loss         (1,717,101) (1,717,101)
Balance at Jun. 30, 2020 $ 41 $ 46,268 $ 111,527,859 $ 139,631 $ (103,916,195) $ 7,797,604
Balance (in shares) at Jun. 30, 2020 4,092 4,626,755